Humana Inc. (NYSE:HUM) Stake Lowered by Accretive Wealth Partners LLC

Accretive Wealth Partners LLC decreased its position in shares of Humana Inc. (NYSE:HUM) by 2.5% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,243 shares of the insurance provider’s stock after selling 83 shares during the period. Accretive Wealth Partners LLC’s holdings in Humana were worth $1,027,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. CarsonAllaria Wealth Management Ltd. lifted its stake in shares of Humana by 111.4% in the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock valued at $28,000 after purchasing an additional 39 shares during the last quarter. Creative Financial Designs Inc. ADV boosted its stake in shares of Humana by 244.0% during the 3rd quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock worth $27,000 after acquiring an additional 61 shares in the last quarter. Atwood & Palmer Inc. acquired a new position in shares of Humana during the 3rd quarter valued at about $29,000. Hantz Financial Services Inc. bought a new position in shares of Humana in the 2nd quarter valued at approximately $35,000. Finally, Family Firm Inc. acquired a new stake in Humana in the 2nd quarter worth approximately $37,000. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently commented on HUM. Truist Financial dropped their price target on shares of Humana from $400.00 to $260.00 and set a “hold” rating on the stock in a research report on Friday, October 11th. UBS Group dropped their target price on shares of Humana from $380.00 to $250.00 and set a “neutral” rating on the stock in a report on Friday, October 4th. JPMorgan Chase & Co. upped their price target on shares of Humana from $332.00 to $396.00 and gave the company a “neutral” rating in a report on Wednesday, August 21st. Sanford C. Bernstein upgraded Humana from a “market perform” rating to an “outperform” rating and set a $308.00 price objective on the stock in a research note on Tuesday, October 8th. Finally, Piper Sandler lowered Humana from an “overweight” rating to a “neutral” rating and lowered their target price for the company from $392.00 to $274.00 in a report on Thursday, October 3rd. Twenty research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat, Humana has a consensus rating of “Hold” and a consensus target price of $315.86.

Humana Trading Up 0.8 %

Shares of HUM opened at $296.39 on Friday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76. The company has a market cap of $35.69 billion, a price-to-earnings ratio of 26.25, a PEG ratio of 2.19 and a beta of 0.52. The stock has a fifty day moving average price of $277.30 and a two-hundred day moving average price of $330.79. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $527.18.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.48 by $0.68. The business had revenue of $29.30 billion for the quarter, compared to the consensus estimate of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. Analysts predict that Humana Inc. will post 15.86 EPS for the current fiscal year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be given a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.19%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana’s dividend payout ratio (DPR) is presently 31.36%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.